XML 21 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statement of Income (Loss) - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 24,575 $ 24,610 $ 26,161
Operating expenses      
Cost of sales 14,447 14,983 15,853
Selling, general and administrative expenses 4,221 19,198 7,232
Research, development and related expenses 1,085 1,154 1,160
Gain on business divestitures [1] 0 (36) (2,724)
Goodwill impairment expense [1] 0 0 271
Total operating expenses 19,753 35,299 21,792
Operating income (loss) 4,822 (10,689) 4,369
Other expense (income), net 3 582 165
Income (loss) from continuing operations before income taxes 4,819 (11,271) 4,204
Provision (benefit) for income taxes 804 (2,867) 188
Income (loss) from continuing operations of consolidated group 4,015 (8,404) 4,016
Income (loss) from unconsolidated subsidiaries, net of taxes 9 18 11
Net income (loss) from continuing operations including noncontrolling interest 4,024 (8,386) 4,027
Less: Net income (loss) attributable to noncontrolling interest 15 16 14
Net income (loss) from continuing operations attributable to 3M 4,009 (8,402) 4,013
Net income (loss) from discontinued operations, net of taxes 164 1,407 1,764
Net income (loss) attributable to 3M $ 4,173 $ (6,995) $ 5,777
Weighted average 3M common shares outstanding - basic (in shares) 550.8 553.9 566.0
Earnings (loss) per share from continuing operations — basic (in dollars per share) $ 7.28 $ (15.17) $ 7.09
Earnings (loss) per share from discontinued operations — basic (in dollars per share) 0.30 2.54 3.12
Earnings (loss) per share — basic (in dollars per share) $ 7.58 $ (12.63) $ 10.21
Weighted average 3M common shares outstanding - diluted (in shares) 552.4 553.9 567.6
Earnings (loss) per share from continuing operations — diluted (in dollars per share) $ 7.26 $ (15.17) $ 7.07
Earnings (loss) per share from discontinued operations — diluted (in dollars per share) 0.29 2.54 3.11
Earnings (loss) per share — diluted (in dollars per share) $ 7.55 $ (12.63) $ 10.18
[1] The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of discontinued operations in the 3M Consolidated Balance Sheet.